Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Laura Concas"'
Autor:
Luca Pisano, Osama Al Jamal, Michela Sanna, Laura Concas, Gesuina Cherchi, Antonella Boi, Marinella Ariu, Pierpaolo Mascia, Giorgio Marras, Irene Urrai, Domenico Galimi
Publikováno v:
Journal of Pediatric and Neonatal Individualized Medicine, Vol 12, Iss 1, Pp e120101-e120101 (2022)
Recent studies have shown the possible negative effects of children’s early exposure to digital content with particular reference to screen time. In fact, excessive use of Digital Media (DM) can have important repercussions on development, learning
Externí odkaz:
https://doaj.org/article/53cb801519944939b6e01db9f339c90a
Autor:
Claudio Vernieri, Daniela Femia, Sara Pusceddu, Carlo Capella, Juan Rosai, Giuseppina Calareso, Laura Concas, Natalie Prinzi, Giuseppe Lo Russo, Filippo de Braud, Roberto Buzzoni
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 2, Pp 432-439 (2016)
We report the case of a 38-year-old patient who was diagnosed with a cerebellar well-differentiated neuroendocrine tumor (WDNET) in 2009. At first glance, we believed that it was a metastasis from an unrecognized WDNET arising outside the cerebellum.
Externí odkaz:
https://doaj.org/article/2933d0faa1c744c5a0463ddabbcbef30
Autor:
Sara Pusceddu, Elena Verzoni, Natialie Prinzi, Alessia Mennitto, Daniela Femia, Paolo Grassi, Laura Concas, Claudio Vernieri, Giuseppe Lo Russo, Giuseppe Procopio
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Neuroendocrine tumors (NETs) are a heterogeneous class of diseases characterized by challenging management. Preclinical evidence shows that the PI3K/AKT/mTOR signaling pathway plays a central role in the pathogenesis and progression of NETs. Everolim
Externí odkaz:
https://doaj.org/article/0db38af5bc5f44f08925c3792391ab5a
Autor:
Laura Concas, Clizia Zichi, Piero Ferolla, Nicola Fazio, Mariangela Torniai, Nada Riva, Filippo de Braud, Francesco Di Costanzo, Stefano Partelli, Maria Pia Brizzi, Maria Rinzivillo, Lucio Giustini, Toni Ibrahim, Calogero Gucciardino, Sabina Murgioni, Stefano Cascinu, Oronzo Brunetti, Francesco Panzuto, Gianfranco Delle Fave, Benedetta Ferretti, Massimo Falconi, Alberto Bongiovanni, Nicola Silvestris, E. Testa, Francesca Spada, Rossana Berardi, Sara Pusceddu, Lorenzo Antonuzzo, Federica Freddari
Publikováno v:
Cancer Medicine
The aim of this work is to assess if cumulative dose (CD) and dose intensity (DI) of everolimus may affect survival of advanced pancreatic neuroendocrine tumors (PNETs) patients. One hundred and sixteen patients (62 males and 54 females, median age 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df6cc1d354db66966f1c93b94facb61
http://europepmc.org/articles/PMC5504331
http://europepmc.org/articles/PMC5504331
Autor:
Daniela Femia, Sara Pusceddu, Giuseppina Calareso, Natalie Prinzi, Roberto Buzzoni, Carlo Capella, Juan Rosai, Laura Concas, Giuseppe Lo Russo, Claudio Vernieri, Filippo de Braud
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 9, Iss 2, Pp 432-439 (2016)
Case Reports in Oncology, Vol 9, Iss 2, Pp 432-439 (2016)
We report the case of a 38-year-old patient who was diagnosed with a cerebellar well-differentiated neuroendocrine tumor (WDNET) in 2009. At first glance, we believed that it was a metastasis from an unrecognized WDNET arising outside the cerebellum.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2cd5a7774a79de1900d3c98049c1e14
http://europepmc.org/articles/PMC5043191
http://europepmc.org/articles/PMC5043191
Autor:
Alice Indini, Laura Concas, Barbara Formisano, Claudio Vernieri, Roberto Buzzoni, Giuseppe Lo Russo, Daniela Femia, Filippo de Braud, Sara Pusceddu
Publikováno v:
Oncotarget
// Sara Pusceddu 1,2 , Filippo De Braud 1,2 , Giuseppe Lo Russo 1,2 , Laura Concas 1,2 , Daniela Femia 1,2 , Claudio Vernieri 1,2 , Alice Indini 1,2 , Barbara Formisano 1,2 and Roberto Buzzoni 1,2 1 Medical Oncology Department, ENETs Center of Excell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481257b43f416237c08b25b2a672079a
https://doi.org/10.18632/oncotarget.8601
https://doi.org/10.18632/oncotarget.8601
Autor:
Cristina Bregant, Marco Maccauro, Sara Pusceddu, Vincenzo Mazzaferro, Livia Leuzzi, Massimo Milione, Filippo de Braud, Laura Concas, Barbara Formisano, Alice Lorenzoni, Fabrizio Festinese, Roberto Buzzoni
Publikováno v:
Future Oncology. 11:1947-1959
ABSTRACT Neuroendocrine neoplasms (NENs) are a group of heterogeneous tumors. The present review discusses current therapeutic strategies for the treatment of gastro-entero-pancreatic NEN. Several systemic options are currently available, including m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0fa2122d300b5cdfb6b5c2cec8bb0f
https://doi.org/10.2217/fon.15.86
https://doi.org/10.2217/fon.15.86
Autor:
Roberto Buzzoni, Sara Pusceddu, Iolanda Pulice, Filippo de Braud, Daniela Femia, Massimo Milione, Laura Concas, Elena Tamborini, Claudio Vernieri, Natalie Prinzi, Giuseppe Lo Russo, Federica Perrone, Francesca Corti
Publikováno v:
Future oncology (London, England). 13(19)
Metformin (MET) has recently emerged as a potentially active agent in cancer prevention and treatment. MET is thought to exert its antitumor effects either via modification of systemic metabolism or through cell-autonomous effects (e.g., activation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6a6e63df112eabd41d92b930829fb1
https://pubmed.ncbi.nlm.nih.gov/28580793
https://pubmed.ncbi.nlm.nih.gov/28580793
Autor:
Marilina Duro, Sara Pusceddu, Anna La Salvia, Paola Ermacora, Laura Concas, Natalie Prinzi, Annalisa Fontana, Filippo de Braud, Salvatore Tafuto, Giuseppe Lo Russo, Vincenzo Mazzaferro, Francesca Spada, Rossana Berardi, Dario Giuffrida, Emilio Bajetta, Maria Rinzivillo, P. Razzore, Claudio Vernieri, Antongiulio Faggiano, Luca Giacomelli, Francesco Panzuto, Vittorio Perfetti, Massimo Di Maio, Francesca Aroldi, Francesco Di Costanzo, Lorenzo Antonuzzo, Daniela Femia, Gianfranco Delle Fave, Massimo Milione, Silvio Ken Garattini, Carlo Carnaghi, Roberto Buzzoni, Nicole Brighi, Sara Cingarlini, Carolina Cauchi, Mariangela Torniai, Silvia Ortolani, Nicola Fazio, Chiara De Divitiis, Laura Catena, Ivana Puliafito, Federica Cavalcoli, Maria Pia Brizzi, Alberto Zaniboni, Sergio Ricci, Maria Vittoria Davì, Alberto Bongiovanni, Davide Campana, Toni Ibrahim, Riccardo Marconcini, Sara Massironi, Annamaria Colao
Publikováno v:
Gastroenterology. 155(2)
BACKGROUND & AIMS: Metformin seems to have anticancer effects. However, it is not clear whether use of glycemia and metformin affect outcomes of patients with advanced pancreatic neuroendocrine tumors (pNETs). We investigated the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dcfecbab2c6a6d2cb38f547e8767c26
https://pubmed.ncbi.nlm.nih.gov/29655834
https://pubmed.ncbi.nlm.nih.gov/29655834
Autor:
Alessia Mennitto, Giuseppe Procopio, Natialie Prinzi, Claudio Vernieri, Paolo Grassi, Giuseppe Lo Russo, Sara Pusceddu, Elena Verzoni, Daniela Femia, Laura Concas
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Neuroendocrine tumors (NETs) are a heterogeneous class of diseases characterized by challenging management. Preclinical evidence shows that the PI3K/AKT/mTOR signaling pathway plays a central role in the pathogenesis and progression of NETs. Everolim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639e6bda23a34cf5949339eef6f67051
http://hdl.handle.net/11573/1018484
http://hdl.handle.net/11573/1018484
